TD Cowen Raises Globe Life Price Target to $215, Maintains Buy Rating

Key Facts

1TD Cowen analyst Andrew Kligerman raised the price target for Globe Life from $199 to $215 while maintaining a Buy rating.

2The new price target indicates a projected increase of 8.04% from current levels.

3The company achieved a GF Score of 85/100, driven by strong growth and momentum, despite recent insider sales totaling $30.1 million.

Amid sustained analyst optimism within the insurance sector, TD Cowen analyst Andrew Kligerman raised the price target for Globe Life from $199 to $215 while maintaining a Buy rating. The new target implies a projected upside of 8.04% from current market levels. The company achieved a notable GF Score of 85/100, driven by robust growth and momentum, even as reports highlighted recent insider sales totaling $30.1 million.

This bullish adjustment follows a strong performance in early 2024, where Globe Life reported a 25% increase in Q1 net income to $2.78 per diluted share, according to company filings. When compared to industry peers like MetLife, which has also shown resilient earnings, GL continues to demonstrate superior operational momentum. Market data suggests that the company's fundamental strength is currently outweighing valuation concerns raised by some technical metrics.

Globe Life (GL) shares stood at $170.76 at the close of June 18, 2026, fluctuating between a high of $172.74 and a low of $169.55 during that session. Investors should monitor the $169.50 support level as a key indicator for continued upward momentum toward the $215 target. Upcoming catalysts include the broader impact of recent Fed interest rate decisions, which remain a critical driver for the investment portfolios of life insurance providers.